Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Active Not Recruiting Phase 2 Trials for Treosulfan (DB11678)

IndicationStatusPhase
DBCOND0029236 (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01894477Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid LeukemiaTreatment